Alternative polyadenylation and miR-34 family members regulate tau expression

Journal of Neurochemistry

Volumn 127, Issue 6, 2013, Pages 739-749

  Dickson, John R ^a   Kruse, Carla ^a,b   Montagna, Daniel R ^a   Finsen, Bente ^b   Wolfe, Michael S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

3 untranslated region; Alzheimer's disease; gene regulation; MAPT; neurodegenerative disease

Indexed keywords

MICRORNA; MICRORNA 34A; TAU PROTEIN;

3' UNTRANSLATED REGION; ALZHEIMER DISEASE; ARTICLE; CELL STRAIN; CELL STRAIN M17D; CELL STRAIN SH SY5Y; CONTROLLED STUDY; GENE FUNCTION; HUMAN; HUMAN CELL; MULTIGENE FAMILY; NEUROBLASTOMA CELL; POLYADENYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN RNA BINDING; REGULATORY MECHANISM; RNA DEGRADATION;

EID: 84890121012     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12437     Document Type: Article

References (46)

1. Abramoff M. D., Magalhaes P. J., and, Ram S. J., (2004) Image processing with ImageJ. Biophotonics Int. 11, 36-42.
2. Agostini M., Tucci P., Killick R.,., et al. (2011a). Neuronal differentiation by TAp73 is mediated by microRNA-34a regulation of synaptic protein targets. Proc. Natl Acad. Sci. USA. 108, 21093-21098.
3. Agostini M., Tucci P., Steinert J. R.,., et al. (2011b). microRNA-34a regulates neurite outgrowth, spinal morphology, and function. Proc. Natl Acad. Sci. USA 108, 21099-21104.
4. Aranda-Abreu G. E., Behar L., Chung S., Furneaux H., and, Ginzburg I., (1999) Embryonic lethal abnormal vision-like RNA-binding proteins regulate neurite outgrowth and tau expression in PC12 cells. J. Neurosci. 19, 6907-6917.
5. Aranha M. M., Santos D. M., Solá S., Steer C. J., and, Rodrigues C. M. P., (2011) miR-34a regulates mouse neural stem cell differentiation. PLoS ONE 6, e21396.
6. Aronov S., Marx R., and, Ginzburg I., (1999) Identification of 3′UTR region implicated in tau mRNA stabilization in neuronal cells. J. Mol. Neurosci. 12, 131-145.
7. Aronov S., Aranda G., Behar L., and, Ginzburg I., (2001) Axonal tau mRNA localization coincides with tau protein in living neuronal cells and depends on axonal targeting signal. J. Neurosci. 21, 6577-6587.
8. Atlas R., Behar L., Sapoznik S., and, Ginzburg I., (2007) Dynamic association with polysomes during P19 neuronal differentiation and an untranslated-region-dependent translation regulation of the tau mRNA by the tau mRNA-associated proteins IMP1, HuD, and G3BP1. J. Neurosci. Res. 85, 173-183.
9. Barrett L. W., Fletcher S., and, Wilton S. D., (2012) Regulation of eukaryotic gene expression by the untranslated gene regions and other non-coding elements. CMLS. Cell. Mol. Life Sci. 69, 3613-3634.
10. Bartel D. P., (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
11. Behar L., Marx R., Sadot E., Barg J., and, Ginzburg I., (1995) cis-acting signals and trans-acting proteins are involved in tau mRNA targeting into neurites of differentiating neuronal cells. Int. J. Dev. Neurosci. 13, 113-127.
12. Betel D., Wilson M., Gabow A., Marks D. S., and, Sander C., (2007) The microRNA.org resource: targets and expression. Nucleic Acids Res. 36, D149-D153.
13. Bommer G. T., Gerin I., Feng Y., et al,. (2007) p53-Mediated Activation of miRNA34 Candidate Tumor-Suppressor Genes. Curr. Biol. 17, 1298-1307.
14. Chen J.-M., Férec C., and, Cooper D. N., (2006) A systematic analysis of disease-associated variants in the 3′ regulatory regions of human protein-coding genes I: general principles and overview. Hum. Genet. 120, 1-21.
15. Cogswell J. P. J., Ward J. J., Taylor I. A. I., et al,. (2008) Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J. Alzheimers Dis. 14, 27-41.
16. Drubin D. G., and, Kirschner M. W., (1986) Tau protein function in living cells. J. Cell Biol. 103, 2739-2746.
17. Encinas M. M., Iglesias M. M., Liu Y. Y., Wang H. H., Muhaisen A. A., Ceña V. V., Gallego C. C., and, Comella J. X. J., (2000) Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells. J. Neurochem. 75, 991-1003.
18. Goedert M., Wischik C. M., Crowther R. A., Walker J. E., and, Klug A., (1988) Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau. Proc. Natl Acad. Sci. USA 85, 4051-4055.
19. Hardy J. A., and, Higgins G. A., (1992) Alzheimer's disease: the amyloid cascade hypothesis. Science 256, 184-185.
20. Hutton M., Lendon C. L., Rizzu P., et al,. (1998) Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393, 702-705.
21. Ittner L. M., Ke Y. D., Delerue F., et al,. (2010) Dendritic function of tau mediates amyloid-β toxicity in Alzheimer's disease mouse models. Cell 142, 387-397.
22. Kosik K. S., Joachim C. L., and, Selkoe D. J., (1986) Microtubule-associated protein tau (τ) is a major antigenic component of paired helical filaments in Alzheimer disease. Proc. Natl Acad. Sci. USA 83, 4044-4048.
23. Krek A., Grün D., Poy M. N., et al,. (2005) Combinatorial microRNA target predictions. Nat. Genet. 37, 495-500.
24. Larcher J.-C., Gasmi L., Viranaïcken W., Eddé B., Bernard R., Ginzburg I., and, Denoulet P., (2004) Ilf3 and NF90 associate with the axonal targeting element of Tau mRNA. FASEB J. 18, 1761-1763.
25. Larkin M. A., Blackshields G., Brown N. P., et al,. (2007) Clustal W and Clustal X version 2.0. Bioinformatics 23, 2947-2948.
26. Lee V. M., Goedert M., and, Trojanowski J. Q., (2001) Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24, 1121-1159.
27. Lewis B. P., Burge C. B., and, Bartel D. P., (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20.
28. Lin Y., Li Z., Ozsolak F., et al,. (2012) An in-depth map of polyadenylation sites in cancer. Nucleic Acids Res. 40, 8460-8471.
29. Maes O. C., Chertkow H. M., Wang E., and, Schipper H. M., (2009) MicroRNA: implications for Alzheimer disease and other human CNS disorders. Curr. Genomics 10, 154-168.
30. Maragkakis M., Reczko M., Simossis V. A., et al,. (2009) DIANA-microT web server: elucidating microRNA functions through target prediction. Nucleic Acids Res. 37, W273-W276.
31. Nukina N., and, Ihara Y., (1986) One of the antigenic determinants of paired helical filaments is related to tau protein. J. Biochem. 99, 1541-1544.
32. Park J. Y., Li W., Zheng D., Zhai P., Zhao Y., Matsuda T., Vatner S. F., Sadoshima J., and, Tian B., (2011) Comparative analysis of mRNA isoform expression in cardiac hypertrophy and development reveals multiple post-transcriptional regulatory modules. PLoS ONE 6, e22391.
33. Poorkaj P., Bird T. D., Wijsman E., Nemens E., Garruto R. M., Anderson L., Andreadis A., Wiederholt W. C., Raskind M., and, Schellenberg G. D., (1998) Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann. Neurol. 43, 815-825.
34. Poorkaj P., Kas A., D'Souza I., Zhou Y., Pham Q., Stone M., Olson M. V., and, Schellenberg G. D., (2001) A genomic sequence analysis of the mouse and human microtubule-associated protein tau. Mamm. Genome 12, 700-712.
35. Rapoport M., Dawson H. N., Binder L. I., Vitek M. P., and, Ferreira A., (2002) Tau is essential to beta -amyloid-induced neurotoxicity. Proc. Natl Acad. Sci. USA 99, 6364-6369.
36. Roberson E. D., Scearce-Levie K., Palop J. J., Yan F., Cheng I. H., Wu T., Gerstein H., Yu G. Q., and, Mucke L., (2007) Reducing endogenous tau ameliorates amyloid-induced deficits in an Alzheimer's disease mouse model. Science 316, 750-754.
37. Schipper H. M., Maes O. C., Chertkow H. M., and, Wang E., (2007) MicroRNA expression in Alzheimer blood mononuclear cells. Gene Regul. Syst. Bio. 1, 263-274.
38. Shi Y., (2012) Alternative polyadenylation: new insights from global analyses. RNA 18, 2105-2117.
39. Spillantini M. G., Murrell J. R., Goedert M., Farlow M. R., Klug A., and, Ghetti B., (1998) Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc. Natl Acad. Sci. USA 95, 7737-7741.
40. Vossel K. A., Zhang K., Brodbeck J., Daub A. C., Sharma P., Finkbeiner S., Cui B., and, Mucke L., (2010) Tau reduction prevents Abeta-induced defects in axonal transport. Science 330, 198.
41. Wang Y., Loomis P. A., Zinkowski R. P., and, Binder L. I., (1993) A novel tau transcript in cultured human neuroblastoma cells expressing nuclear tau. J. Cell Biol. 121, 257-267.
42. Weingarten M.D,. (1975). A protein factor essential for microtubule assembly. Proc. Natl Acad. Sci. USA 72, 1858-1862.
43. Wood J. G., Mirra S. S., Pollock N. J., and, Binder L. I., (1986) Neurofibrillary tangles of Alzheimer disease share antigenic determinants with the axonal microtubule-associated protein tau (tau). Proc. Natl Acad. Sci. USA 83, 4040-4043.
44. Wu H., Huang M., Lu M., Zhu W., Shu Y., Cao P., and, Liu P., (2013) Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel. Cancer Chemother Pharmacol 71, 1159-1171.
45. Yamakuchi M., Ferlito M., and, Lowenstein C. J,. (2008). miR-34a repression of SIRT1 regulates apoptosis. Proc. Natl Acad. Sci. USA 105, 13421-13426.
46. Yang S., Li Y., Gao J., Zhang T., Li S., Luo A., Chen H., Ding F., Wang X., and, Liu Z,. (2013). MicroRNA-34 suppresses breast cancer invasion and metastasis by directly targeting Fra-1. Oncogene 32, 4293-4303.